TIAA Trust, National Association’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.42M Sell
9,611
-3,594
-27% -$773K 0.14% 79
2026
Q1
$2.87M Sell
13,205
-142,305
-92% -$31.6M 0.17% 78
2025
Q4
$35.5M Sell
155,510
-4,498
-3% -$1.02M 0.09% 106
2025
Q3
$37M Sell
160,008
-2,220
-1% -$452K 0.09% 102
2025
Q2
$30.1M Sell
162,228
-10,325
-6% -$1.92M 0.08% 111
2025
Q1
$36.2M Sell
172,553
-1,825
-1% -$355K 0.11% 93
2024
Q4
$31M Sell
174,378
-4,068
-2% -$748K 0.09% 105
2024
Q3
$35.2M Buy
178,446
+1,918
+1% +$358K 0.11% 98
2024
Q2
$30.3M Buy
176,528
+1,012
+0.6% +$168K 0.09% 102
2024
Q1
$32M Sell
175,516
-6,809
-4% -$1.17M 0.1% 99
2023
Q4
$28.3M Sell
182,325
-11,131
-6% -$1.62M 0.09% 103
2023
Q3
$28.8M Buy
+193,456
New +$28.4M 0.1% 100

Other funds holding ABBV

TIAA Trust, National Association's ABBV Position: Q2 2026 in Review

TIAA Trust, National Association reduced its AbbVie (ABBV) stake by 27% in Q2 2026, selling an estimated $773K and leaving 9,611 shares worth $2.42M. The position accounts for 0.14% of the portfolio, ranked #79.

TIAA Trust, National Association first reported a position in ABBV in Q3 2023 and has held it in 12 quarters since. The position peaked at $37M in Q3 2025. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • TIAA Trust, National Association held 9,611 shares of AbbVie worth $2.42M as of Q2 2026.
  • TIAA Trust, National Association sold 3,594 AbbVie shares in Q2 2026, an estimated $773K.
  • AbbVie made up 0.14% of TIAA Trust, National Association's portfolio in Q2 2026, its #79 holding.
  • TIAA Trust, National Association first reported a position in AbbVie in Q3 2023 and has held it in 12 quarters since.
  • TIAA Trust, National Association's AbbVie position peaked at $37M in Q3 2025.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on TIAA Trust, National Association's 13F filing for Q2 2026, filed 10 Aug 2026.